1. Shemesh, Maya, Lochte, Sara, Piehler, Jacob, Schreiber, Gideon. 2021. IFNAR1 and IFNAR2 play distinct roles in initiating type I interferon-induced JAK-STAT signaling and activating STATs. In Science signaling, 14, eabe4627. doi:10.1126/scisignal.abe4627. https://pubmed.ncbi.nlm.nih.gov/34813358/
2. Morand, Eric F, Furie, Richard, Tanaka, Yoshiya, Berglind, Anna, Tummala, Raj. 2019. Trial of Anifrolumab in Active Systemic Lupus Erythematosus. In The New England journal of medicine, 382, 211-221. doi:10.1056/NEJMoa1912196. https://pubmed.ncbi.nlm.nih.gov/31851795/
3. Pairo-Castineira, Erola, Clohisey, Sara, Klaric, Lucija, Wilson, James F, Baillie, J Kenneth. 2020. Genetic mechanisms of critical illness in COVID-19. In Nature, 591, 92-98. doi:10.1038/s41586-020-03065-y. https://pubmed.ncbi.nlm.nih.gov/33307546/
4. Adi, Ghaith, Obaid, Zaki, Hafez, Deema Hassan, Saud, Hajer Abu, Alkateb, Faten Ahmed. 2024. Severe Adverse Reaction to Measles Vaccine Due to Homozygous Mutation in the IFNAR2 Gene: A Case Report and Literature Review. In Journal of clinical immunology, 45, 30. doi:10.1007/s10875-024-01814-6. https://pubmed.ncbi.nlm.nih.gov/39436454/
5. Akter, Shamima, Roy, Arpita Singha, Tonmoy, Mahafujul Islam Quadery, Islam, Md Sajedul. 2021. Deleterious single nucleotide polymorphisms (SNPs) of human IFNAR2 gene facilitate COVID-19 severity in patients: a comprehensive in silico approach. In Journal of biomolecular structure & dynamics, 40, 11173-11189. doi:10.1080/07391102.2021.1957714. https://pubmed.ncbi.nlm.nih.gov/34355676/
6. Fricke-Galindo, Ingrid, Martínez-Morales, Alfonso, Chávez-Galán, Leslie, Guzmán-Guzmán, Iris Paola, Falfán-Valencia, Ramcés. 2022. IFNAR2 relevance in the clinical outcome of individuals with severe COVID-19. In Frontiers in immunology, 13, 949413. doi:10.3389/fimmu.2022.949413. https://pubmed.ncbi.nlm.nih.gov/35967349/
智鼠故事 
